Pioneering 3D Human Tissues for Drug Discovery
Jan 29 | 2026
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
Read More »Apr 23 | 2025
VivoSim to Carry Forward Organovo 3D Bioprinting
Read More »Apr 02 | 2025
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
Read More »
